期刊文献+

心血管事件对老年重症社区获得性肺炎30d病死率的影响 被引量:6

Effects of cardiovascular events on 30-day mortality of elderly patients with severe community-acquired pneumonia
原文传递
导出
摘要 目的探讨心血管事件(CVE)对老年重症社区获得性肺炎(CAP)患者30 d病死率的影响。方法将2012年1月至2014年6月期间符合老年重症CAP诊断标准并入院接受治疗的167例患者纳入研究,按照CAP指南进行规范化治疗。记录患者住院期间CVE发生情况及30 d病死率,采用Kaplan-Meier生存曲线分析合并CVE患者与未合并CVE患者的病死率情况,并采用Logistic多因素回归分析CVE对CAP患者30 d病死率的影响。结果 167例符合标准的重症CAP患者中,30 d病死率为28.7%(48/167),86例发生CVE(51.5%),合并CVE的CAP患者30 d病死率为39.5%(34/86),未合并CVE的CAP患者病死率为17.3%(14/81),两者比较差异有明显统计学意义(Log-rank检验,χ2=10.065,P=0.002)。Logistic多因素回归分析表明,并发CVE是老年重症CAP患者30 d死亡的独立危险因素(OR=1.997,P<0.05)。结论合并CVE的老年重症CAP患者有更高的30 d死亡风险。 Objective To evaluate the effect of cardiovascular events(CVE) on 30-day mortality of elderly patients with severe community-acquired pneumonia(CAP). Methods Totally167 elderly severe CAP patients fulfilled this study inclusion criteria from January 2012 to June2014 in Shanghai Jiaotong University Affiliated Sixth People's Hospital were enrolled. The patients were treated following CAP standard guide. CVE complications and 30-day mortality were recorded.Kaplan-Meier survival curve and multivariate logistic regression analysis were used to assess the effect of CVE on 30-day mortality. Results In total of 167 elderly patients, 86(51.5%)patients developed CVE. The 30-day mortality was 28.7%(48 / 167). The 30-day mortality in the elderly severe CAP patients with CVE complications was higher than the patients without CVE complications [39.5%(34 / 86) vs. 17.3%(14 / 81), Log-rank test, χ2= 10.065, P = 0.002]. Multivariate logistic regression analysis showed that CVE complications was the independent risk factor of30-day mortality for elderly CAP patients(OR = 1.997, P〈0.05). Conclusion CVE complications are common in elderly severe CAP patients, who are at a high risk of 30-day mortality.
出处 《中华危重症医学杂志(电子版)》 CAS 2016年第3期154-158,共5页 Chinese Journal of Critical Care Medicine:Electronic Edition
基金 上海交通大学附属第六人民医院人才培养基金项目(2013025)
关键词 社区获得性肺炎 心血管事件 老年人 Community-acquired pneumonia Cardiovascular events Aged
  • 相关文献

参考文献20

  • 1Simonetti AF, Viasus D, Garcia-Vidal C, et al. Mana- gement of community-acquired pneumonia in older adults [J]. Ther Adv Infect Dis, 2014, 2 (1): 3-16.
  • 2Faverio P, Aliberti S, Bellelli G, et al. The management of community-acquired pneumonia in the elderly[J]. Eur J Intern Med, 2014, 25 (4): 312-319.
  • 3Takaki M, Nakama T, Ishida M, et al. High incidence of community-acquired pneumonia among rapidly aging population in Japan: a prospective hospital-based surveillance[J]. Jpn J Infect Dis, 2014, 67 (4): 269-275.
  • 4Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America / American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults [J]. Clin Infect Dis, 2007, 44 (S2): S27-S72.
  • 5Griffin AT, Wiemken TL, Arnold FW. Risk factors for cardiovascular events in hospitalized patients with community-acquired pneumonia [J]. Int J Infect Dis, 2013, 17 (12): el 125-1129.
  • 6Perry TW, Pugh M J, Waterer GW, et al. Incidence of cardiovascular events after hospital admission for pneumonia[J]. Am J Med, 2011, 124 (3): 244-251.
  • 7Remington LT, Sligl WI. Community-acquired pneumonia[J]. Curr Opin Pulm Med, 2014, 20 (3): 215- 224.
  • 8Wesemann T, Nullmann H, Pflug M, et al. Pneumonia severity, comorbidity and 1-year mortality in predominantly older adults with community-acquired pneumonia: a cohort study[J]. BMC Infect Dis, 2015, 15 (1): 2.
  • 9马潜,吕群,阮肇扬,王建军,戴一帆.谵妄与老年社区获得性肺炎患者住院期间死亡的相关分析[J].中华危重症医学杂志(电子版),2014,7(5):33-36. 被引量:4
  • 10龙威,黄高忠,李利娟,苏文涛,赵立东.D-二聚体对老年重症社区获得性肺炎30天死亡率的预测价值[J].中华老年多器官疾病杂志,2014,13(7):524-527. 被引量:4

二级参考文献18

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3057
  • 2Fry AM, Shay DK, Holman RC, et al. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002[J]. JAMA, 2005, 294(21): 2712-2719.
  • 3Fung HB, Monteagudo-Chu MO. Community-acquired pneumonia in the elderly[J]. Am J Geriatr Pharmacother, 2010, 8(1): 47-62.
  • 4Fine M J, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia[J]. N Engl J Med, 1997, 336(4): 243-250.
  • 5Mandell LA, Wunderink RG Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults[J]. Clin Infect Dis, 2007, 44 Suppl 2: S27-S72.
  • 6Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community- Acquired Pneumonia Intervention Trial Assessing Levofloxacin[J]. JAMA, 2000, 283(6): 749-755.
  • 7Van der Meet V, Neven AK, van den Brock P J, et al. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review[J]. BMJ, 2005, 331(7507): 26.
  • 8Nseir W, Farah R, Mograbi J, et al. Impact of serum C-reactive protein measurements in the first 2 days on the 30-day mortality in hospitalized patients with severe community-acquired pneumonia: a cohort study[J]. J Crit Care, 2013, 28(3): 291-295.
  • 9Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia[J]. Am J Med, 2008, 121(3): 219-225.
  • 10Robert-Ebadi H, Righini M. Diagnosis and management of pulmonary embolism in the elderly[J]. Eur J Intern Meal, 2014, 25(4): 343-349.

共引文献10

同被引文献42

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部